Clinical and Genetic Characterization of Inherited NPRL3 Splice Variants in Two Patients With Epilepsy
Molecular Genetics & Genomic Medicine · 2026-06 · 14 (6)
DOI: 10.1002/mgg3.70240 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, online erschienen am 28.05.2026. Verfasst von Shouxing Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Anhui Provincial Children's Hospital/Children's Hospital of Fudan University (Affiliated Anhui Branch), Hefei, China. Hauptthemen laut MEDLINE: Epilepsy, Phenotype, Tumor Suppressor Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
NPRL3 ‐related epilepsy (NRE) is a GATORopathy characterized by focal seizures, with or without focal cortical dysplasia. Although NPRL3 variants have been associated with syndromes such as familial focal epilepsy with variable foci and sleep‐related hypermotor epilepsy, the genotype–phenotype correlations in NRE remain poorly understood. This study aimed to investigate the clinical and genetic features of NRE in two Chinese families, together with a review of the genotype–phenotype spectrum.
Methods
Two pediatric Chinese patients with NRE were identified through whole‐exome sequencing (WES). Clinical, neuroimaging, laboratory, and genetic data were analyzed. A review of reported NRE cases was conducted.
Results
Inherited NPRL3 splice variants (NM_001077350.3: c.924 + 1G>A and c.925–1G>C) were identified in both probands using WES; both were inherited from their asymptomatic mothers. The patients presented with seizures starting at 1–2 years of age. Proband 1 experienced focal and focal to bilateral tonic–clonic seizures (FBTCS), while Proband 2 had focal seizures. Neuroimaging findings were normal. Patient 1 achieved seizure control with sodium valproate, oxcarbazepine, and lacosamide, while Patient 2 responded to oxcarbazepine and levetiracetam. A literature review of 41 articles identified 94 NPRL3 variants in 84 pedigrees and 23 cohort cases with epilepsy, revealing an estimated penetrance of 76% (162/214). Loss‐of‐function variants predominated (83%), while splice variants were relatively rare (13%). No clear genotype–phenotype correlations were observed, even in cases with identical NPRL3 variants.
Conclusion
The findings of the study highlight the genetic and clinical heterogeneity of NRE, which is characterized by incomplete penetrance and phenotypic variability. This underscores the importance of tailored antiepileptic management and the consideration of NPRL3 variants as causes of familial and sporadic epilepsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Anhui Provincial Children's Hospital/Children's Hospital of Fudan University (Affiliated Anhui Branch), Hefei, China.
Zitieren
APA
Wang, S., Wu, J., Song, C., He, Y., Zhao, Z., & Yang, B. (2026). Clinical and Genetic Characterization of Inherited NPRL3 Splice Variants in Two Patients With Epilepsy. Molecular Genetics & Genomic Medicine, 14(6). https://doi.org/10.1002/mgg3.70240
Vancouver
Wang S, Wu J, Song C, He Y, Zhao Z, Yang B. Clinical and Genetic Characterization of Inherited NPRL3 Splice Variants in Two Patients With Epilepsy. Molecular Genetics & Genomic Medicine. 2026;14(6). doi:10.1002/mgg3.70240
BibTeX
@article{Wang2026,
author = {Wang, Shouxing and Wu, Jihua and Song, Conglei and He, Yuanzhi and Zhao, Zhongli and Yang, Bin},
title = {Clinical and Genetic Characterization of Inherited NPRL3 Splice Variants in Two Patients With Epilepsy},
journal = {Molecular Genetics & Genomic Medicine},
year = {2026},
volume = {14},
number = {6},
doi = {10.1002/mgg3.70240}
}
EUVIMED